Invesco’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$20.5M Hold
2022
Q4
$19.4M Hold
2022
Q3
$17.1M Buy
2022
Q2
$15.1M Buy
2022
Q1
$14.2M Hold
2021
Q4
$14M Buy
2020
Q4
Sell
2020
Q3
$17.5M Buy
2020
Q2
$14M Buy